Loading...
Bristol-Myers Squibb Company PFD CONV 2
BMYMP•PNK
HealthcareDrug Manufacturers - General
$790.00
$0.00(0.00%)
Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) Stock Overview
Explore Bristol-Myers Squibb Company PFD CONV 2’s financial performance, market position, analyst ratings, and future outlook.
Revenue Growth
7.32%
↑ 7.32%
Profit Growth
$41.11
↓ 211.50%
EPS Growth
$41.11
↓ 213.60%
Operating Margin
18.45%
↓ 65.86%
ROE
31.93%
↓ 211.50%
Dividend Yield
0.00%
↑ 4.58%
Analyst Recommendations data is not available for BMYMPAnalyst Recommendations details for BMYMP are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.
Headquarters
Princeton, DE
Founded
2003